Bingjun Sun
Impact in
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
- Biomaterials 75
- Nanoparticle-Based Drug Delivery 74
-
- Nanoplatforms for cancer theranostics 61
- Co-authors
- Zhonggui He (99 shared papers)Jin Sun (89 shared papers)Cong Luo (39 shared papers)Xuanbo Zhang (22 shared papers)Shiyi Zuo (26 shared papers)Haotian Zhang (10 shared papers)Qiming Kan (11 shared papers)Qin Chen (6 shared papers)
- Journals
- Journal of Controlled Release (12 papers)Nano Letters (7 papers)Nano Today (5 papers)Asian Journal of Pharmaceutical Sciences (5 papers)Acta Pharmaceutica Sinica B (4 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Bingjun Sun
103 papers receiving 5.2k citations
Bingjun Sun's Hit Papers
Peers
Comparison fields: 5 of 115
- Biomaterials 2.6k
- Biomedical Engineering 3.2k
- Pharmaceutical Science 262
- Molecular Biology 2.0k
- Pulmonary and Respiratory Medicine 878
Countries citing papers authored by Bingjun Sun
This map shows the geographic impact of Bingjun Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingjun Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingjun Sun more than expected).
Fields of papers citing papers by Bingjun Sun
This network shows the impact of papers produced by Bingjun Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingjun Sun. The network helps show where Bingjun Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Bingjun Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 391 | |
| 2 | Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy Hit paper breakdown → | 2018 | 370 |
| 3 | 2014 | 301 | |
| 4 | 2019 | 268 | |
| 5 | 2020 | 242 | |
| 6 | Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy Hit paper breakdown → | 2022 | 216 |
| 7 | 2020 | 179 | |
| 8 | 2021 | 167 | |
| 9 | 2016 | 158 | |
| 10 | 2019 | 147 | |
| 11 | 2017 | 142 | |
| 12 | 2019 | 140 | |
| 13 | 2020 | 104 | |
| 14 | 2020 | 99 | |
| 15 | 2019 | 96 | |
| 16 | 2020 | 93 | |
| 17 | 2021 | 93 | |
| 18 | 2021 | 76 | |
| 19 | 2018 | 72 | |
| 20 | 2022 | 72 |
About Bingjun Sun
Bingjun Sun is a scholar working on Biomaterials, Biomedical Engineering, Molecular Biology, Materials Chemistry and Oncology, having authored 115 papers that have together received 5.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (74 papers), Nanoplatforms for cancer theranostics (61 papers), RNA Interference and Gene Delivery (21 papers), Advanced biosensing and bioanalysis techniques (18 papers), Photodynamic Therapy Research Studies (11 papers), Dendrimers and Hyperbranched Polymers (9 papers), Advanced Nanomaterials in Catalysis (9 papers) and Advanced Drug Delivery Systems (9 papers). The work is most often cited by research in Biomaterials (2.6k citations), Biomedical Engineering (3.2k citations), Pharmaceutical Science (262 citations), Molecular Biology (2.0k citations) and Pulmonary and Respiratory Medicine (878 citations). Bingjun Sun has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Zhonggui He, Jin Sun, Cong Luo, Xuanbo Zhang, Shiyi Zuo, Haotian Zhang, Qiming Kan, Qin Chen, Shenwu Zhang and Yu Han. Their work appears in journals such as Journal of Controlled Release, Nano Letters, Nano Today, Asian Journal of Pharmaceutical Sciences and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.